Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a late-stage pharmaceutical company with a broad ...
Two posters presented at the 2024 American Society of Hematology meeting reported real-world outcomes data for patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback